About Ginova UK Limited
Ginova UK Limited incorporates a large modern temperature controlled and monitored production unit comprising of 14 fully equipped production rooms staffed by our professional and efficient teams of Production Operatives.
We offer a competitive and professional service tailored to our individual customer requirements.
Ginova UK Limited holds an MHRA Wholesale Dealers Licence (WL 25973) and an MHRA Manufacturers (Assembly Only) Licence (MIA 25973).
Our Market Research department works closely with our Buying and Regulatory Teams to seek new and exciting lines launched in the UK and Europe. This enables us to expand on the range of products we are importing.
Ginova has been the first to market many new licences for Parallel Imported products and strives to continue with this success. Ginova fully understands the vital importance of market research for the continued growth of the company.
Our Regulatory team works closely with all the departments within Ginova, to ensure MHRA licence applications and EMA notifications are submitted in the most efficient and cost-effective manner. The team also ensures that the licence portfolio is maintained and kept completely up-to-date with the latest information.
We pride ourselves on keeping current and up to date with any industry regulatory changes and were one of the first parallel importers to implement Braille onto repackaged pharmaceuticals. We also worked very closely with another parallel importer to obtain the required user testing for patient leaflets. More recently, the EMA have introduced an Annual Update to ensure the industry keep their Notifications up to date. Also, our team recently attended a meeting with the MHRA to begin the new 'Tell and Do' variations for some selected changes on PLPI licences.
Our Purchasing Team has over 15 years of experience in Europe and has built up some excellent relationships with suppliers enabling us to purchase a good range of genuine products from our very trustworthy sources.
As our licence portfolio increases, we are also expanding on the number of contacts throughout Europe and would welcome any new contacts.
Please contact us at firstname.lastname@example.org.
We have a vigilant Quality Control Team, who works very closely with our experienced Qualified Persons (QPs), to ensure products are genuine and repackaged in accordance with the PI product licences.
All components required for repackaging are also subject to stringent QC checks prior to use.
Finished EU pharmaceuticals are only released upon final consideration by our QPs.
Good Manufacturing Practice (GMP) is the part of quality assurance which ensures that medicinal products are consistently produced and controlled to the quality standards appropriate to their intended use and as required by the marketing authorisation (MA) or product specification. GMP is concerned with both production and quality control.
Good Distribution Practice (GDP) is the part of quality assurance which ensures that products are consistently stored, transported and handled under suitable conditions as required by the marketing authorisation (MA) or product specification.